Blecharczyk, M. (2026) “Orforglipron as a Small-Molecule GLP-1 Receptor Agonist: A New Era of Incretin-Based Oral Therapy?”, Quality in Sport, 56, p. 72512. doi: 10.12775/QS.2026.56.72512.